Download PDF
Rev Bras Ginecol Obstet 2016; 38(03): 140-146
DOI: 10.1055/s-0036-1571472
Original Article
Thieme Publicações Ltda Rio de Janeiro, Brazil

Assessment of the Effects of Tribulus Terrestris on Sexual Function of Menopausal Women

Avaliação dos efeitos do Tribulus Terrestris na sexualidade de mulheres no climatério
Sóstenes Postigo
1   Department of Obstetrics and Gynecology, School of Medical Sciences, Santa Casa de São Paulo—FCMSCSP, São Paulo, SP, Brazil
,
Sônia Maria Rolim Rosa Lima
1   Department of Obstetrics and Gynecology, School of Medical Sciences, Santa Casa de São Paulo—FCMSCSP, São Paulo, SP, Brazil
,
Silvia Saito Yamada
1   Department of Obstetrics and Gynecology, School of Medical Sciences, Santa Casa de São Paulo—FCMSCSP, São Paulo, SP, Brazil
,
Benedito Fabiano dos Reis
2   Department of Obstetrics and Gynecology, Universidade do Vale Do Sapucaí—UNIVAS, Minas Gerais (MG), Brazil
,
Gustavo Maximiliano Dutra da Silva
3   Graduate Program, School of Medical Sciences, Santa Casa de São Paulo, São Paulo, SP; Universidade São Francisco Campus of Bragança Paulista, Bragança Paulista, SP, Brazil
,
Tsutomu Aoki
1   Department of Obstetrics and Gynecology, School of Medical Sciences, Santa Casa de São Paulo—FCMSCSP, São Paulo, SP, Brazil
› Author Affiliations
Further Information

Publication History

18 November 2015

02 December 2015

Publication Date:
22 February 2016 (online)

   Permissions and Reprints

Abstract

Objective The aim of this study was to study the effects of Tribulus terrestris on sexual function in menopausal women.

Methods This was a prospective, randomized, double-blind, placebo-controlled clinical trial that included 60 postmenopausal women with sexual dysfunction. The women were divided into two groups, placebo group and Tribulus group, and evaluated by using the Sexual Quotient—female version (SQ-F) and Female Intervention Efficacy Index (FIEI) questionnaires.

Results There was no significant difference between the groups in age, age at menopause, civil status, race, and religion. In the evaluation with the SQ-F questionnaire, there were significant differences between the placebo (7.6 ± 3.2) and Tribulus (10.2 ± 3.2) groups in the domains of desire and sexual interest (p ≤ 0.001), foreplay (3.3 ± 1.5 versus 4.2 ± 1.0) (p ≤ 0.01), arousal and harmonious interaction with the partner (5.7 ± 2.1 versus 7.2 ± 2.6) (p ≤ 0.01), and comfort in sexual intercourse (6.5 ± 2.4 versus 8.0 ± 1.9) (p ≤ 0.01). There was no significant difference between the placebo and Tribulus groups in the domains of orgasm and sexual satisfaction (p = 0.28). In the FIEI questionnaire, there was a significant improvement (p < 0.001) in the domains of vaginal lubrication during coitus and/or foreplay (20 versus 83.3%), sensation in the genitalia during sexual intercourse or other stimuli (16.7 versus 76.7%), sensation in the genital region (20 versus 70%), sexual intercourse and/or other sexual stimulations (13.3 versus 43.3%), and the ability to reach orgasm (20% versus 73.3%). There was no significant difference in adverse effects between the two groups.

Conclusions After 90 days of treatment, at the doses used, we found Tribulus terrestris to be effective in treating sexual problems among menopausal women.

Resumo

Objetivo Estudar os efeitos do Tribulus terrestris na função sexual de mulheres após a menopausa.

Métodos Ensaio clínico, prospectivo, randomizado, duplo-cego, placebo controlado, com 60 mulheres após a menopausa com disfunção sexual, divididas em dois grupos: Grupo Placebo e Grupo Tribulus, avaliadas através dos questionários Quociente Sexual-versão Feminina (QS-F) e Female Intervention Efficacy Index (FIEI).

Resultados Não houve diferença significante entre os grupos quanto à idade, idade de menopausa, estado civil, raça e religião. Na avaliação do questionário QS-F houve diferença significante entre os grupos Placebo (7,6 ± 3,2) e Tribulus (10,2 ± 3,2) nos aspectos desejo e interesse sexual (p ≤ 0,001), preliminares (3,3 ± 1,5 versus 4,2 ± 1,0) (p ≤ 0,01), excitação da mulher e sintonia com o parceiro (5,7 ± 2,1 versus 7,2 ± 2,6) (p ≤ 0,01) e no aspecto conforto na relação sexual (6,5 ± 2,4 versus 8,0 ± 1,9) (p ≤ 0,01). O aspecto orgasmo e satisfação sexual não houve diferença significante entre o Grupo Placebo e Tribulus (p = 0,28). No questionário FIEI houve melhora significante (p < 0,001) na lubrificação vaginal durante o coito e/ou preliminares (20 versus 83,3%), na sensação nas genitálias durante a relação sexual ou outros estímulos (16,7 versus 76,7%), na sensação na área genital (20 versus 70%), nas relações sexuais e/ou outras estimulações sexuais (13,3 versus 43,3%) e na capacidade de ter orgasmo (20% versus 73,3%). Quanto aos efeitos colaterais não houve diferença significante entre os dois Grupos.

Conclusões Após noventa dias, podemos concluir que o Tribulus terrestris nas doses utilizadas demonstrou ser efetivo no tratamento das queixas sexuais das mulheres após a menopausa.

Keywords

sexuality - menopause - physiological sexual dysfunction - tribulus - phytotherapeutic medicines

Palavras-chave

sexualidade - menopausa - disfuncão sexual fisiológica - Tribulus - medicamentos fitoterápicos
 

  • References

  • 1 Kaiser FE. Sexual function and the older woman. Clin Geriatr Med 2003; 19 (3) 463-472 , v
    CrossrefPubMedGoogle Scholar
  • 2 Santana TGM, Lima SMRR, Silva HFS, Gonçalves N. Fitomedicamentos e sexualidade. In: Lima SMRR. Fitomedicamentos na prática ginecológica e obstétrica. 2a ed. São Paulo, Brazil: Ateneu.; 2009: 131-43
    Google Scholar
  • 3 Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281 (6) 537-544
    CrossrefPubMedGoogle Scholar
  • 4 Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006; 13 (1) 46-56
    CrossrefPubMedGoogle Scholar
  • 5 Burri A, Hilpert P, Spector T. Longitudinal evaluation of sexual function in a cohort of pre- and postmenopausal women. J Sex Med 2015; 12 (6) 1427-1435
    CrossrefPubMedGoogle Scholar
  • 6 Abdo CHN. Elaboração e validação do quociente sexual-versão feminina: uma escala para avaliar a função sexual da mulher. Rev Bras Med 2006; 63 (9) 477-482
    PubMedGoogle Scholar
  • 7 Lonnèe-Hoffmann RA, Dennerstein L, Lehert P, Szoeke C. Sexual function in the late postmenopause: a decade of follow-up in a population-based cohort of Australian women. J Sex Med 2014; 11 (8) 2029-2038
    CrossrefPubMedGoogle Scholar
  • 8 Schwenkhagen A. Hormonal changes in menopause and implications on sexual health. J Sex Med 2007; 4 (Suppl. 03) 220-226
    CrossrefPubMedGoogle Scholar
  • 9 Rozenberg S, Gevers R, Peretz A, Vandromme J, Robyn C, Ham H. Decrease of bone mineral density during estrogen substitution therapy. Maturitas 1993; 17 (3) 205-210
    CrossrefPubMedGoogle Scholar
  • 10 Davis SR. Androgens and female sexuality. J Gend Specif Med 2000; 3 (1) 36-40
    PubMedGoogle Scholar
  • 11 Adaikan PG, Gauthaman K, Prasad RN, Ng SC. Proerectile pharmacological effects of Tribulus terrestris extract on the rabbit corpus cavernosum. Ann Acad Med Singapore 2000; 29 (1) 22-26
    PubMedGoogle Scholar
  • 12 Gauthaman K, Adaikan PG, Prasad RN. Aphrodisiac properties of Tribulus Terrestris extract (Protodioscin) in normal and castrated rats. Life Sci 2002; 71 (12) 1385-1396
    CrossrefPubMedGoogle Scholar
  • 13 Gauthaman K, Ganesan AP. The hormonal effects of Tribulus terrestris and its role in the management of male erectile dysfunction—an evaluation using primates, rabbit and rat. Phytomedicine 2008; 15 (1–2) 44-54
    CrossrefPubMedGoogle Scholar
  • 14 Shamloul R. Natural aphrodisiacs. J Sex Med 2010; 7 (1 Pt 1): 39-49
    CrossrefPubMedGoogle Scholar
  • 15 De Combarieu E, Fuzzati N, Lovati M, Mercalli E. Furostanol saponins from Tribulus terrestris. Fitoterapia 2003; 74 (6) 583-591
    CrossrefPubMedGoogle Scholar
  • 16 Kostova I, Dinchev D. Saponins in Tribulus terrestris-chemistry and bioactivity. Phytochem Rev 2005; 4 (2) 111-137
    CrossrefPubMedGoogle Scholar
  • 17 Sun W, Gao J, Tu G, Guo Z, Zhang Y. A new steroidal saponin from Tribulus terrestris Linn. Nat Prod Lett 2002; 16 (4) 243-247
    CrossrefPubMedGoogle Scholar
  • 18 Nian H, Qin LP, Chen WS, Zhang QY, Zheng HC, Wang Y. Protective effect of steroidal saponins from rhizome of Anemarrhena asphodeloides on ovariectomy-induced bone loss in rats. Acta Pharmacol Sin 2006; 27 (6) 728-734
    CrossrefPubMedGoogle Scholar
  • 19 Mazaro-Costa R, Andersen ML, Hachul H, Tufik S. Medicinal plants as alternative treatments for female sexual dysfunction: utopian vision or possible treatment in climacteric women?. J Sex Med 2010; 7 (11) 3695-3714
    CrossrefPubMedGoogle Scholar
  • 20 Arsyad KM. Effect of protodioscin on the quantity and quality of sperms from males with moderate idiopathic oligozoospermia. Medika 1996; 22 (8) 614-618
    PubMedGoogle Scholar
  • 21 Adimoelja A. Phytochemicals and the breakthrough of traditional herbs in the management of sexual dysfunctions. Int J Androl 2000; 23 (Suppl. 02) 82-84
    CrossrefPubMedGoogle Scholar
  • 22 Neychev VK, Mitev VI. The aphrodisiac herb Tribulus terrestris does not influence the androgen production in young men. J Ethnopharmacol 2005; 101 (1–3) 319-323
    CrossrefPubMedGoogle Scholar
  • 23 Akhtari E, Raisi F, Keshavarz M , et al. Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study. Daru 2014; 22: 40
    CrossrefPubMedGoogle Scholar
  • 24 Yialamas MA, Hayes FJ. Androgens and the ageing male and female. Best Pract Res Clin Endocrinol Metab 2003; 17 (2) 223-236
    CrossrefPubMedGoogle Scholar
  • 25 Mameri Filho J, Haidar MA, Soares Junior JM, Baracat EC. Effects of the association of estrogen and androgen in postmenopausal women. Rev Bras Ginecol Obstet 2005; 27 (3) 118-124
    PubMedGoogle Scholar
  • 26 Davis SR, van der Mooren MJ, van Lunsen RH , et al. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause 2006; 13 (3) 387-396
    CrossrefPubMedGoogle Scholar
  • 27 Panay N, Al-Azzawi F, Bouchard C , et al. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric 2010; 13 (2) 121-131
    CrossrefPubMedGoogle Scholar
  • 28 Berman LA, Berman JR, Werbin T, Chabra S, Goldstein I. The use of the Female Intervention Efficacy Index (FIEI) as an immediate outcome measure of medical intervention to treat female sexual dysfunction. J Sex Marital Ther 2001; 27 (5) 427-433
    CrossrefPubMedGoogle Scholar
  • 29 Rowland D, Tai W. A review of plant-derived and herbal approaches to the treatment of sexual dysfunctions. J Sex Marital Ther 2003; 29 (3) 185-205
    CrossrefPubMedGoogle Scholar
  • 30 Al-Azzawi F, Bitzer J, Brandenburg U , et al. Therapeutic options for postmenopausal female sexual dysfunction. Climacteric 2010; 13 (2) 103-120
    CrossrefPubMedGoogle Scholar
  • 31 Bancroft J. The endocrinology of sexual arousal. J Endocrinol 2005; 186 (3) 411-427
    CrossrefPubMedGoogle Scholar
  • 32 Bradford A, Meston CM. Behavior and symptom change among women treated with placebo for sexual dysfunction. J Sex Med 2011; 8 (1) 191-201
    CrossrefPubMedGoogle Scholar
  • 33 Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 2008; 59: 565-590
    CrossrefPubMedGoogle Scholar